Maze Therapeutics MAZE
NASDAQ MAZE
$26.43 -0.22 (-0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Other Accumulated Expenses (2024 - 2026)

Updated

Maze Therapeutics (MAZE) posted Other Accumulated Expenses of $7.01 million for Q2 2026, up 41.7% from $4.95 million a year earlier and up 39.0% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics' Other Accumulated Expenses came in at $4.31 million, up 46.7% from FY2024.

  • In prior years, Maze Therapeutics' Other Accumulated Expenses was $2.93 million in FY2024.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $5.04 million (Q1 2026), $4.31 million (Q4 2025) and $5.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Maze Therapeutics 1.47 Bn 1.47 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.01 Mn
Mar 31, 2026 5.04 Mn
Dec 31, 2025 4.31 Mn
Sep 30, 2025 5.07 Mn
Jun 30, 2025 4.95 Mn
Dec 31, 2024 2.93 Mn
API Access

Maze Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MAZE&period=max&api_key=YOUR_API_KEY